XNAS · NRXP
-1.63% · -$0.0497 · Vol 685.9K
After hours · updated 18:21:36 ET
NRX Pharmaceuticals, Inc. Common Stock

NRX Pharmaceuticals, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$3.00
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
NRXP
NRX Pharmaceuticals, Inc. Common Stock
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

37/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NRXP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NRXP catalysts
About NRX Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
29
Country
US

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.02
Day high
$3.11
Day low
$2.90
Previous close
$3.05
52W high
$4.62
-35.06% from high
52W low
$1.68
45% of range
Market cap
$130.5M
EPS
$-0.0400
Beta
1.96
Shares out
42.8M
Volume
685.9K
0.73× rel vol
Avg volume
934.2K
VWAP
$3.04
Price history computed in-house
1W
-7.11%
1M
-23.95%
3M
-1.95%
1Y
+13.65%
YTD
+10.71%
SMA 50 $3.96 · below
SMA 200 $2.78 · above
52W position 45%

NRXP overview

Veridion Score
37
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NRXP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NRXP Form 4 filings
Public disclosures

Congress activity in NRXP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NRXP in the cached public ledger.

Federal contracts

NRXP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NRXP in this window.
Lobbying spend

NRXP lobbying filings, year to date.

Registered lobbying filings matched to NRX Pharmaceuticals, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NRXP in this window.
Loading news for NRXP
Analyst ratings
Sovereign unlock shows live analyst consensus for NRXP.
Options
Sovereign unlock shows live options positioning for NRXP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.